Stock Track | Repligen Plummets 9.69% Intraday on Disappointing FY26 Earnings Guidance

Stock Track

Feb 24

Repligen's stock plummeted 9.69% during intraday trading on Tuesday, following the release of the company's financial results and outlook.

The biotechnology tools company reported strong fourth-quarter 2025 results, with adjusted earnings per share of $0.49 beating the consensus estimate of $0.44 and revenue of $198 million surpassing the expected $192.9 million. However, investor sentiment turned negative due to the company's fiscal 2026 guidance.

Repligen provided full-year 2026 earnings guidance in the range of $1.93 to $2.01 per share, which fell short of the analyst consensus estimate of $2.07 per share. While revenue guidance of $810 million to $840 million was roughly in line with expectations, the lower-than-anticipated earnings outlook prompted a sell-off.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1182419118"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182419118\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182419118?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-24 22:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182419118","market":"nz","top_or_hot":-1,"title":"Stock Track | Repligen Plummets 9.69% Intraday on Disappointing FY26 Earnings Guidance","media":"Stock Track","content":"<p>Repligen's stock plummeted 9.69% during intraday trading on Tuesday, following the release of the company's financial results and outlook.</p><p>The biotechnology tools company reported strong fourth-quarter 2025 results, with adjusted earnings per share of $0.49 beating the consensus estimate of $0.44 and revenue of $198 million surpassing the expected $192.9 million. However, investor sentiment turned negative due to the company's fiscal 2026 guidance.</p><p>Repligen provided full-year 2026 earnings guidance in the range of $1.93 to $2.01 per share, which fell short of the analyst consensus estimate of $2.07 per share. While revenue guidance of $810 million to $840 million was roughly in line with expectations, the lower-than-anticipated earnings outlook prompted a sell-off.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Repligen Plummets 9.69% Intraday on Disappointing FY26 Earnings Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Repligen Plummets 9.69% Intraday on Disappointing FY26 Earnings Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-24 22:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Repligen's stock plummeted 9.69% during intraday trading on Tuesday, following the release of the company's financial results and outlook.</p><p>The biotechnology tools company reported strong fourth-quarter 2025 results, with adjusted earnings per share of $0.49 beating the consensus estimate of $0.44 and revenue of $198 million surpassing the expected $192.9 million. However, investor sentiment turned negative due to the company's fiscal 2026 guidance.</p><p>Repligen provided full-year 2026 earnings guidance in the range of $1.93 to $2.01 per share, which fell short of the analyst consensus estimate of $2.07 per share. While revenue guidance of $810 million to $840 million was roughly in line with expectations, the lower-than-anticipated earnings outlook prompted a sell-off.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RGEN","symbol_name":"Repligen Corporation","start_time":0,"source_url":"","article_id":"1182419118","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182419118","pubTimestamp":1771943913,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Repligen's stock plummeted 9.69% during intraday trading on Tuesday, following the release of the company's financial results and outlook.The biotechnology tools company reported strong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RGEN":"Repligen Corporation"},"translate_title":"个股追踪|Repligen盘中暴跌9.69%因2026财年盈利指引令人失望","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RGEN":1},"content_text":"Repligen's stock plummeted 9.69% during intraday trading on Tuesday, following the release of the company's financial results and outlook.The biotechnology tools company reported strong fourth-quarter 2025 results, with adjusted earnings per share of $0.49 beating the consensus estimate of $0.44 and revenue of $198 million surpassing the expected $192.9 million. However, investor sentiment turned negative due to the company's fiscal 2026 guidance.Repligen provided full-year 2026 earnings guidance in the range of $1.93 to $2.01 per share, which fell short of the analyst consensus estimate of $2.07 per share. While revenue guidance of $810 million to $840 million was roughly in line with expectations, the lower-than-anticipated earnings outlook prompted a sell-off.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}